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Abstract
DNA methylation patterns change dynamically during mammalian development and lineage specification, yet scarce
information is available about how DNA methylation affects gene expression profiles upon differentiation. Here we
determine genome-wide transcription profiles during undirected differentiation of severely hypomethylated (Dnmt12/2)
embryonic stem cells (ESCs) as well as ESCs completely devoid of DNA methylation (Dnmt12/2;Dnmt3a2/2;Dnmt3b2/2 or
TKO) and assay their potential to transit in and out of the ESC state. We find that the expression of only few genes mainly
associated with germ line function and the X chromosome is affected in undifferentiated TKO ESCs. Upon initial
differentiation as embryoid bodies (EBs) wild type, Dnmt12/2 and TKO cells downregulate pluripotency associated genes
and upregulate lineage specific genes, but their transcription profiles progressively diverge upon prolonged EB culture.
While Oct4 protein levels are completely and homogeneously suppressed, transcription of Oct4 and Nanog is not
completely silenced even at late stages in both Dnmt12/2 and TKO EBs. Despite late wild type and Dnmt12/2 EBs showing a
much higher degree of concordant expression, after EB dissociation and replating under pluripotency promoting conditions
both Dnmt12/2 and TKO cells, but not wild type cells rapidly revert to expression profiles typical of undifferentiated ESCs.
Thus, while DNA methylation seems not to be critical for initial activation of differentiation programs, it is crucial for
permanent restriction of developmental fate during differentiation.
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Introduction
Embryonic stem cells (ESCs) are pluripotent cells derived from
the naı¨ve epiblast of preimplantation blastocysts. Under appro-
priate conditions they can self renew indefinitely in the pluripotent
state, as well as differentiate into any embryonic lineage, including
germ cells, both in vitro and upon reintroduction in host embryos
[1]. These properties make ESCs a powerful and popular model to
investigate the molecular bases of pluripotency and lineage
commitment. Indefinite self renewal of mouse ESCs is sustained
by LIF/JAK/Stat3, PI3K/Akt and Wnt singalling as well as
suppression of the FGF/Erk and GSK3 pathways [2–11]. These
conditions support the expression of master transcriptional
regulators of pluripotency, including Oct4, Nanog and Sox2
[12–15]. These transcription factors establish a core network that,
in cooperation with epigenetic modifiers, non coding RNAs and
the c-Myc transcriptional network, orchestrates the pluripotency
expression program and suppresses differentiation programs [16–
18] (reviewed in [19,20]). Recent data suggest that the same core
pluripotency factors also play crucial roles in initial cell fate
choices. Differentiation signals directly modulate Oct4 and Sox2
protein levels, leading to changes in their genome wide binding
profiles and thus initiating lineage selection without prior
activation of lineage specification factors [21].
By indexing chromatin states through DNA and histone
modification, epigenetic factors ensure stable propagation of
transcription programs and thus contribute to cell identity. At
the same time, epigenetic marks are typically reversible and the
enzymatic systems that set and erase them respond directly or
indirectly to environmental signals, providing the necessary
plasticity for the dynamic changes of transcription programs
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required for progressive differentiation. Although many epigenetic
factors and chromatin remodelers have a role in stabilizing the
pluripotent ESC state (i.e., sustained self renewal and absence of
spontaneous differentiation), most are actually not strictly required
for its establishment and/or maintenance (as opposed to bona fide
core pluripotency factors). This property and the demonstration
that ESC self renewal is minimally dependent on extrinsic
signaling have led to the concept that the pluripotent state of
naı¨ve epiblast and ESCs represents a ground proliferative state
relatively independent from epigenetic regulation [22,23]. In
contrast, most epigenetic regulators are required for proper
execution of transcriptional programs driving lineage commitment
and progression of differentiation [20].
In mammals DNA methylation plays major roles in the control
of gene expression during development and differentiation [24–
26]. The importance of DNA methylation for proper development
is underscored by the embryonic lethal phenotypes of mice lacking
major DNA methyltransferases (Dnmts) [27–29]. These as well as
many other studies have established that Dnmt3a and Dnmt3b,
together with the catalytically inactive co-factor Dnmt3L, set DNA
methylation patterns during embryogenesis and gametogenesis,
while Dnmt1 is mainly responsible for maintaining these patterns
through cell replication [30–34]. However, further studies have
shown that Dnmt3 enzymes are also required for long term
maintenance of DNA methylation patterns [35–38] and for their
dynamic modulation in processes other than development [39,40].
In embryos with homozygous inactivation of single Dnmt genes as
well as in double Dnmt3a and 3b null (Dnmt3 DKO) embryos
development arrests well after gastrulation, clearly showing that
these enzymes are dispensable for the formation of naı¨ve epiblast
[28,29]. In addition, corresponding Dnmt null ESCs can be
readily derived from blastocysts or by direct gene targeting even in
the case of triple knockout (TKO) of all catalytically active Dnmts
(Dnmt1, 3a and 3b) [28,29,41]. Dnmt1 null ESCs have about 20%
residual genomic methylation, mostly located in repetitive
sequences [28,36,42]. TKO ESCs exhibit complete loss of
genomic methylation, clearly showing that neither Dnmts nor
DNA methylation are required for survival and self renewal of
ESCs. Restoring Dnmt1 expression rescues the ability of Dnmt1
null ESCs to form teratomas, contribute to chimeras and
complement tetraploid embryos [42,43]. Analogously, the ability
to form teratomas is restored in Dnmt3 DKO ESCs upon
expression of either Dnmt3 protein [36]. Therefore, functional
pluripotency of ESCs is not permanently compromised by the loss
of either Dnmt1 or Dnmt3 proteins and consequent loss of DNA
methylation.
Previous studies pointed to a very limited developmental
potential of Dnmt1 null ESCs and to impaired survival or
proliferation of their differentiated progeny [28,44,45]. Other
studies showed that, in contrast to wt counterparts, Dnmt1 null
ESCs differentiated as embryoid bodies (EBs) express high levels of
trophoblast markers and, under appropriate conditions, can be
differentiated into trophoblast derivatives [45,46]. Similarly, it has
been reported that TKO ESCs exhibit a growth defect and
increased apoptosis upon EB differentiation and that cells from
TKO nuclear transfer embryos aggregated with wt embryos
mostly contribute to extraembryonic tissues, in addition to [41,47].
However, in the latter study a few TKO cells were detected in the
embryo proper till an early postgastrulation stage (E8.5), but their
identity was not defined. Thus, it is not clear to what extent
globally hypomethylated cells are able to commit to and progress
along definitive embryonic lineages.
To investigate how DNA methylation contributes to differen-
tiation programs, we subjected wt, Dnmt12/2 and TKO ESCs to
undirected differentiation as EBs. Our results clearly show that
hypomethylated cells initiate differentiation programs by down-
regulating pluripotency genes and upregulating markers of
differentiated lineages. In particular, we show a previously
unappreciated progression of differentiation programs in
Dnmt12/2 EBs. However, by dissociating late EBs and replating
their cells under culture conditions that promote pluripotency, we
found that hypomethylated cells fully revert to the undifferentiated
ESC state, indicating that DNA methylation is crucial for
canalization of developmental fate during differentiation.
Results
Incomplete silencing of pluripotency gene transcription
upon differentiation of globally hypomethylated ESCs
To gain insights into the specific role of DNA methylation in
silencing pluripotency associated genes during differentiation, we
generated EBs from wt, Dnmt12/2 and TKO ESCs and analyzed
transcript levels as well as promoter DNA methylation of the
pluripotency genes Oct4 (also known as Pou5f1) and Nanog (Fig. 1).
Interestingly, wt and Dnmt12/2 EBs showed a drastic down
regulation of both genes already by day 4, whereas DNA
methylation of the respective promoters could be detected only
by day 8. The observation that initial silencing of Oct4 precedes
methylation of its promoter is consistent with previous work
showing recruitment of Dnmt3a by the GCNF-MBD3 complex to
the Oct4 promoter in advance of detectable DNA methylation [49–
52]. To investigate the dependence of silencing and promoter
methylation of Oct4 and Nanog on the catalytic activity of Dnmt1
during differentiation we established clones of Dnmt12/2 ESCs
stably expressing GFP fusions of wt Dnmt1 (GFP-Dnmt1wt) or a
catalytically inactive single point mutant (GFP-Dnmt1C1229W) [48]
and subjected them to the same differentiation procedure as above
(Fig. S1). While silencing and promoter methylation of Oct4 and
Nanog in Dnmt12/2 EBs were largely restored to the levels present
in wt ESCs by expression of GFP-Dnmt1wt, they were essentially
unchanged in Dnmt12/2 EBs expressing GFP-Dnmt1C1229W. This
shows that reduced promoter methylation and silencing of Oct4
and Nanog in Dnmt12/2 EBs largely depend on the lack of Dnmt1
catalytic activity.
Consistent with an earlier report [47], TKO EBs also showed
initial reduction of Nanog transcript levels, albeit more limited
than in wt and Dnmt12/2 EBs (Fig. 1A). In contrast, Oct4 silencing
was remarkably delayed in TKO EBs. Importantly, in both
Dnmt12/2 and TKO EBs reduction of Oct4 and Nanog transcript
levels was partial as compared to wt EBs. Significant residual levels
of both Oct4 and Nanog transcripts were detectable even in late
mutant EBs and correlated with the extent of Dnmt gene deletions
as well as with relative promoter methylation levels in the case of
Oct4 (Fig. 1), indicating that Dnmt3a and 3b contribute to the
intermediate levels of Oct4 and Nanog silencing in Dnmt12/2 EBs.
Taken together, these results reveal that promoter methylation
is dispensable for initial silencing of Oct4 and Nanog, but necessary
for complete extinction of their transcriptional activity during
differentiation.
Complete and uniform downregulation of Oct4 protein
levels in hypomethylated EBs
We then asked whether the residual Oct4 transcript levels lead
to residual Oct4 protein in dnmt12/2 and TKO EBs and whether
downregulation of Oct4 protein occurs homogenously in EBs or
subpopulations of cells retain high Oct4 protein levels. To address
this question, we followed Oct4 protein levels during EB formation
by immunofluorescent staining after cell dissociation and FACS
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analysis (Fig. 2). All ESC lines displayed similar levels of Oct4
protein in the pluripotent state. After 4 days of differentiation, only
about 2% of cells from wt EBs were Oct4 positive, but higher
numbers of positive cells were detected in mutant EBs. As
observed at the transcript level (Fig. 1), a substantial delay in
downregulation was also found for Oct4 protein levels in TKO
EBs as about 13% of cells were still Oct4 positive at day 4. Again
dnmt12/2 EBs showed a less dramatic phenotype at day 4 as only
4.75% of their cells still contained detectable Oct4 protein.
Surprisingly, regardless of genotype Oct4 positive cells were about
1% at day 8 and below 1% by day 12. At the latter time point
Oct4 staining profiles showed no distinct cell subpopulation
expressing high levels Oct4 protein and were indistinguishable
among genotypes and from the background profiles of the
antibody isotype control. We conclude that, despite incomplete
extinction of Oct4 transcription, the downregulation of Oct4
protein during differentiation is complete and uniform also in
hypomethylated cells.
DNA methylation is dispensable for activation of
differentiation programs
As we found that hypomethylated cells are capable of partially
silencing the master pluripotency genes Oct4 and Nanog as well as
completely suppressing Oct4 protein levels, we next asked whether
these cells are able to activate differentiation programs. To address
this question, we performed genome-wide microarray expression
analysis of undifferentiated wt, Dnmt12/2 and TKO ESCs and
corresponding EBs at day 4 and 16 of differentiation in two
independent experiments. Principal component analysis (PCA)
showed that data points segregate according to day of differentiation
and genotype (Fig. 3A). The three undifferentiated ESC lines were
relatively closely clustered, suggesting that their expression profiles
are very similar. However, principal component 1 provided a clear
differentiation signature, as it increased continuously with EB
culture time. This increase was less pronounced for the knockout
genotypes, reflecting a crucial contribution of DNA methylation to
the control of gene expression during differentiation. At both
differentiation time points Dnmt12/2 EBs were at an intermediate
distance along the median line between TKO and wt EBs, again
emphasizing the less severe phenotype of Dnmt12/2 EBs compared
to TKO EBs.
Using a two-fold cutoff and false discovery rate below 5%, we
determined gene expression changes in undifferentiated Dnmt12/2
and TKO ESCs relative to wt ESC lines (Fig. 3B). In addition, we
measured gene expression changes for each genotype between the
undifferentiated ESC state and day 4 EBs (Fig. 3C), as well as
between day 4 and day 16 EBs (Fig. 3D). Differentially expressed
genes and their expression fold change are listed in Table S5 (d0),
S6 (d0–4) and S7 (d4–16). As suggested by PCA, very few genes
showed altered expression in undifferentiated hypomethylated
ESCs (Dnmt12/2 54, TKO 82). As DNA methylation is mostly
considered to be involved in gene silencing [53], we reasoned that
decreased expression in hypomethylated ESCs/EBs is most likely
due to indirect effects. Therefore, we focused most of our analyses
on upregulated genes in mutant ESCs/EBs. Gene ontology (GO)
enrichment analysis of the 57 genes upregulated in TKO ESCs
Figure 1. Partial silencing of oct4 and nanog in Dnmt12/2 and TKO EBs. Oct4 and Nanog transcript levels (upper panels) and respective
promoter methylation (lower panels) during differentiation of wt, Dnmt12/2 and TKO ESCs as EBs. Transcript levels were measured by RT-qPCR and
are shown relative to wt ESCs (day 0). DNA methylation levels were determined by bisulfite conversion followed by PCR and pyrosequencing. Five
and 4 CpG sites in the proximal promoter regions of oct4 and nanog, respectively, were analyzed and respective values were averaged. Mean values
and standard errors of 2 and 3 biological replicates are shown for DNA methylation and expression analyses, respectively. Asterisks indicate
significance levels: * p,0.05; ** p,0.001; *** p,0.0001 (Student t-test).
doi:10.1371/journal.pone.0052629.g001
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revealed categories involved in reproductive processes like
oogenesis and spermatogenesis (Fig. S2A). In contrast, no enriched
category could be identified for the 49 genes upregulated in
Dnmt12/2 ESCs. However, in both mutant ESC lines, disregu-
lated genes were frequently located on the X chromosome
(Dnmt12/2 13.1%; TKO 40.4%) and in Dnmt12/2 ESCs also on
the Y chromosome (13.3%). Furthermore, in both mutant ESC
lines about 60% of the upregulated transcripts are known to
exhibit testis specific expression. These data are consistent with
previous results from Fouse et al. [54], where a Dnmt3 DKO ESC
line with constitutive knockdown of Dnmt1 was analyzed.
Surprisingly though, only 60 out of 274 genes that we identified
as differentially expressed in TKO ESCs were found disregulated
also in the previous study. This may at least in part be due to the
less stringent cutoff criteria used in Fouse et al. as when we
compared the GO terms associated with disregulated genes, we
found a more substantial overlap between the two studies (Fig.
S2B).
In the first differentiation period (d0–4) changes in transcript
levels were observed for approximately the same number of genes
in wt (1255) and Dnmt12/2 EBs (1230), two thirds of which (833)
changed expression concordantly in the two EB populations. In
comparison, total gene expression changes in TKO EBs were
roughly two thirds (819) of those in wt EBs, but the concerted
changes (376) were only one third of them (Fig. 3C and D).
Importantly, in the second differentiation period (d4–16) the
expression levels of 1808 genes changed in wt EBs, while roughly
half (879) and one fifth (406) of expression changes were detected
in Dnmt12/2 and TKO EBs, respectively. With respect to the
expression changes in wt EBs one third (593) and only one tenth
(187) were actually concordant in Dnmt12/2 and TKO EBs,
respectively. The initial high proportions of concomitant gene
expression changes in mutant and wt EBs suggest that hypo-
methylated cells can activate differentiation programs to substan-
tial extents. However, the further decrease of concordant gene
expression changes seen between day 4 and 16 suggests that
progression of differentiation programs in mutant EBs was
impaired. This was particularly pronounced in TKO EBs,
indicating that the presence of Dnmt3 proteins allows hypomethy-
lated Dnmt12/2 EBs to execute differentiation programs to an
extent that is more similar to that of wt EBs.
After the first four days of differentiation 365 genes showed
similar expression changes in wt and mutant EBs (Fig. 3C). GO
analysis of the 198 upregulated genes in this group revealed
significant enrichment in categories related to developmental
processes like anatomical structure development, system and organ
development and cell differentiation (Fig. S3A). By contrast, the
167 genes that were downregulated in EBs of all three genotypes
Figure 2. Uniform downregulation of Oct4 protein levels during EB differentiation. Undifferentiated ESCs colonies (day 0) and EBs at
indicated stages of differentiation (day 4–12) were dissociated into single cells, stained with an Oct4 specific antibody and subjected to FACS analysis.
Shaded curves depict Oct4 intracellular staining. Dashed lines indicate isotype controls and horizontal bars represent individual gates for positive
Oct4 signals. The overlay shows exclusively Oct4 positive signals for each cell line. Numbers in red, blue and green indicate the percentages of Oct4
positive cells in wt, Dnmt12/2 and TKO ESCs/EBs, respectively, after subtraction of background signal from isotype controls.
doi:10.1371/journal.pone.0052629.g002
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were significantly enriched in genes involved in stem cell
maintenance and development as well as genes expressed in ESCs
and embryonic germ cells (EGCs) (Fig. S3B and S3C). These data
clearly show that all three ESC lines initiated differentiation
programs by downregulating genes associated with pluripotent
stem cell states and upregulating genes required for developmental
processes.
Differentiation programs progress further in Dnmt12/2
than in TKO EBs
Examination of gene changes in the second period of EB
differentiation (day 4–16) revealed that only 145 genes were
concordantly expressed in wt, Dnmt12/2 and TKO EBs. Enriched
GO categories for the 129 concerted up regulated genes in all
three cell lines were involved in lipid metabolic processes and were
mainly expressed in extraembryonic tissues (Fig. S4). Importantly,
substantially more genes were concomitantly regulated in wt and
Dnmt12/2 EBs after both differentiation periods. In the first four
days, in addition to the 365 genes with concordant expression
changes in all three genotypes, 468 more genes were commonly
regulated in wt and Dnmt12/2 EBs (Fig. 3C). From the 210
upregulated genes of this group the most highly enriched GO
terms were associated with developmental processes, including cell
differentiation and proliferation, tissue and organ development
(Fig. S5), and Kegg pathway analysis indicated enrichment for
genes involved in signaling pathways, including the Wnt and TGF-
b pathways (not shown). Furthermore, the 258 genes that were
commonly downregulated in day 4 wt and Dnmt12/2 EBs yielded
35 enriched GO categories including regulation of expression,
metabolism and developmental processes (not shown). During the
second differentiation period (day 4–16) 446 genes were also
concordantly regulated in wt and Dnmt12/2 EBs, with 90% (402)
upregulated genes (Fig. 3D). The latter genes were enriched in GO
terms mainly associated with cell adhesion, hemostasis, organ
development and metabolism (Fig. S6A) and are known to be
expressed in various tissues like liver, plasma and kidney (Fig.
S6C), while the few genes that were commonly downregulated (44)
were related to GO categories of pattern specification and
embryonic development (Fig. S6B). These observations reveal a
previously unappreciated progression of differentiation programs
in Dnmt12/2 EBs and show that Dnmt12/2 cells respond more to
EB differentiation conditions than TKO cells.
To gain a measure of the developmental potential of Dnmt12/2
and TKO EBs we compared their expression changes relative to
wt EBs in greater detail and focused on changes occurring during
the first four days of differentiation as TKO EBs seemed unable to
progress substantially in the following 12 days (day 4–16). We
plotted the expression changes in either TKO or Dnmt12/2 EBs
relative to wt EBs for all genes (25528) (Fig. 4A and B). In this
analysis we used a two-fold cutoff as well, but did not filter for false
discovery rate, resulting in higher numbers of gene expression
changes than in the case of Fig. 3C. Data points clustered much
closer to the diagonal line in the plot showing expression changes
in Dnmt12/2 relative to wt EBs (Fig. 4B), confirming the higher
concordance of gene changes between these EB populations. We
identified 2397 genes that do not respond to the differentiation
conditions in TKO EBs (‘‘non-responders’’; green dots in Fig. 4A).
By tracking these genes in the expression change plot for Dnmt12/2
versus wt EBs it becomes evident that more than half of these genes
(1298 out of 2397) did respond similarly in Dnmt12/2 and wt EBs.
Figure 3. Genome-wide expression analysis of wt, Dnmt12/2
and TKO ESCs during differentiation as EBs. RNA samples from
undifferentiated ESCs and respective EBs at day 4 and 16 of
differentiation were subjected to microarray expression analysis. A)
Two dimensional principal component analysis of independent
biological duplicates per cell line per time point. B) Venn diagram of
differentially expressed genes in Dnmt12/2 (blue circles) and TKO
(green circles) ESCs with respect to wt ESCs. (C, D) Venn diagram of
gene changes occurring between day 0–4 (C) and day 4–16 (D) in
knockout and wt (red circles) EBs. Gene changes occurring during the
two differentiation intervals in wt and mutant EBs were determined and
compared. Larger numbers indicate total numbers of gene changes,
whereas smaller numbers refer to up- (q) and down- (Q) regulated
genes in the respective sectors. Data were averaged from independent
biological duplicates.
doi:10.1371/journal.pone.0052629.g003
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This analysis also confirmed that in total 70% of gene expression
changes were concordant between wt and Dnmt12/2 EBs.
The further progress of differentiation programs in Dnmt12/2
relative to TKO EBs suggests that expression of Dnmt3a and 3b
proteins endows Dnmt12/2 cells with greater differentiation
potential. To support this concept we analyzed Dnmt3a and 3b
transcript levels in wt and Dnmt12/2 EBs after 4 and 16 days of
culture. Consistent with previous immunofluorescence data on
embryos [55] Dnmt3b transcripts progressively declined in wt EBs,
while Dnmt3a transcripts first decreased in early EBs and then
recovered at the later stage. As compared to wt EBs higher levels
of Dnmt3b transcripts were detected in both early and late
Dnmt12/2 EBs, while Dnmt3a transcript levels were the same and
lower at day 4 and 16, respectively, (Fig. S7). Interestingly, Dnmt3b
promoter activity was shown to be controlled by DNA methylation
[56], which could explain the higher levels of Dnmt3b transcripts
in hypomethylated Dnmt12/2 EBs. Thus, high Dnmt3b levels may
contribute to the further progression of differentiation programs in
Dnmt12/2 versus TKO EBs.
Silencing of most bivalent genes during early EB
differentiation does not require de novo methylation or
Dnmt proteins
In mouse ESCs, approximately three thousand genes feature
chromatin domains with frequent trimethylation of both lysines 4
and 27 in histone H3 (H3K4me3 andH3K27me3), marks usually
found separately in chromatin with opposite transcriptional
potential. These bivalent genes encode lineage specific factors
and were shown to be transcriptionally poised for rapid activation
upon differentiation [57,58]. Interestingly, recent work showed
that 93% of all bivalent promoters contain CpG islands and
suggested a transition from the bivalent state to DNA methylation
upon differentiation of ESCs to neural progenitors [59]. To test
whether a similar switch occurs more generally in undirected EB
differentiation conditions we applied the gene expression analysis
shown above to bivalent and non-bivalent gene sets separately
(Fig. S8). Despite the different numbers of genes, this revealed
similar distributions for the separate gene sets as for all genes
together, indicating that there is no general trend for genes which
are bivalent in the ESC state to be silenced by DNA methylation
or Dnmt protein-dependent mechanisms during early differenti-
ation. Instead, a tendency could be observed for bivalent genes not
to change their expression levels under EB differentiation
conditions (i.e., to cluster more at the center of the plots in Fig.
S8). This is expected due to the heterogeneous cell type
composition in EBs, as bivalent genes are activated only in specific
cell types and kept silent in all other lineages.
Dnmts are required for silencing selected bivalent genes
during differentiation
We also analyzed genes that were upregulated exclusively in
Dnmt12/2 and/or TKO EBs as DNA methylation and/or Dnmt3
proteins may be critical for their repression. The 107 genes
upregulated in both Dnmt12/2 and TKO EBs during the first
differentiation period (Fig. 3C) were enriched in GO terms for
developmental processes like system and organ development as
well as anatomical structure development (Fig. S9A). Intriguingly,
GO enrichment analysis revealed that several genes exclusively
upregulated in either Dnmt12/2 or TKO EBs play a role in
nervous system development (Fig. S9B and D) and, in the case of
TKO EBs, many are known to be expressed in the brain (Fig.
S9C). Upregulated genes in TKO EBs involved in neural
differentiation included Nestin, Hes6, Fapb7/Blbp, Otx2 and Fzd3,
which have roles in neural tube patterning and neural progenitors
[60]. Interestingly, Nestin and Otx2 are bivalent in ESCs and may
have been missed in our global analysis of bivalent gene expression
in hypomethylated EBs (Fig. S8B). To investigate whether selected
bivalent genes, including genes expressed in neural progenitors,
are controlled by DNA methylation or Dnmt proteins we analyzed
CpG island methylation of Nestin (all ectodermal progenitors) and
Sox1 (early neuroepithelial progenitors) during EB differentiation
of wt cells and verified their expression in wt, Dnmt12/2 and TKO
ESCs and EBs (Fig. 5 and Fig. S10). The same analyses were
extended to Fgf5 and Brachyury as representatives of non-neural
bivalent genes (primitive ectoderm and early mesoderm, respec-
Figure 4. Genome-wide expression changes in early wt, Dnmt12/2 and TKO EBs. Scatter plots of genome-wide expression changes
between day 0 and 4 in TKO (A) and Dnmt12/2 EBs (B) relative to wt EBs. Data points are heat-colored according to their local density. About 17% of
25528 analyzed genes changed expression level in wt EBs according to the thresholds indicated by the vertical dotted lines. Genes whose expression
levels increased and decreased in wt but not in TKO EBs (‘‘TKO non-responders’’, parts of the corridor between the horizontal dotted lines to the left
and right of the vertical dotted lines in A) are marked in green in both A and B and their numbers are reported in green in the respective sectors.
doi:10.1371/journal.pone.0052629.g004
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tively) and Tet1, a non-bivalent gene that is rapidly silenced upon
EB differentiation [61]. The expression profiles of Nestin, Sox1, Fgf5
and Brachury were altered in mutant ESCs/EBs, although to
variable extents and at different time points. Interestingly, among
these bivalent genes an increase in CpG island methylation during
differentiation was seen only for Nestin and Sox1 (Fig. 5B and D).
The distribution of methylated sites in the different clones
obtained by bisulfite sequencing is consistent with increased
methylation of these genes in selected lineages. In contrast, all
clones in the Tet1 bisulfite analysis showed increased methylation,
although Tet1 transcript levels were not affected in mutant EBs
(Fig. 5C). These data are consistent with a requirement of Dnmts
for silencing of selected bivalent genes.
Hypomethylated cells isolated from late EBs revert to the
undifferentiated state
We showed that Oct4 protein levels were completely downreg-
ulated in hypomethylated EBs, although silencing of Oct4 and
Nanog transcription was partial relative to wt EBs. At the same time
hypomethylated EBs were able to activate differentiation pro-
grams, but their progression was altered to an extent that
correlated with the presence of Dnmt3 proteins. Thus, we
wondered whether cells from Dnmt12/2 and TKO EBs could
revert to the undifferentiated state in conditions that promote
pluripotency. To test this we dissociated 12 days old wt, Dnmt12/2
and TKO EBs into single cells, plated equal cell numbers in the
presence or absence of LIF and analyzed the expression of
pluripotency associated genes as well as markers of differentiated
lineages after one (R1), two (R2) or three days (R3; Fig. 6). We
chose 12 days old EBs as our results clearly demonstrated that at
this stage Oct4 protein levels were homogenously down regulated
in all living cells regardless of genotype (Fig. 2). As expected, upon
replating wt cells maintained a heterogeneous, differentiated
morphology (not shown) and their transcript levels of pluripotency
associated factors as well as Fgf5 and Brachury showed essentially
no response regardless of the presence or absence of LIF. Indeed,
Fgf5 and Brachury are only transiently expressed in the embryonic
primitive ectoderm and early mesoderm and in EBs they peaked at
time points before day 12 (not shown). Instead, Eomes is expressed
in trophoectodermal derivatives and showed drastic downregula-
tion upon EB dissociation, pointing to a role of cell-to cell contacts
in promoting its expression. In contrast to cells from wt EBs, cells
dissociated from Dnmt12/2 and TKO EBs rapidly formed colonies
with the characteristic morphology of undifferentiated ESCs (not
shown) and upregulated transcript levels of pluripotency associated
factors within 24 h. Strikingly, in dissociated Dnmt null cells
upregulation of Oct4, Nanog and Tet1 was observed also upon
culture without LIF, pointing to a role of cell-to-cell contact in
restraining the expression of these genes. However, Oct4, Nanog
and Tet1 transcript levels were significantly lower in the absence
than in the presence of LIF and in TKO cells they decreased to
similar levels as in corresponding day 12 EBs. In dissociated Dnmt
mutant cells cultured with LIF not only were Oct4, Nanog and
Tet1 transcripts upregulated to higher levels already 24 h after
replating, but their levels were maintained or even increased in the
following days so that at least by the third day they were similar to
the levels originally found in the respective undifferentiated ESC
cultures. In dissociated Dnmt mutant cells the expression of
differentiated lineage markers decreased or increased depending
on the presence or absence of LIF, respectively. Again, expression
levels similar to those originally present in the undifferentiated
ESC cultures were reached in the presence of LIF, while in the
absence of LIF they were the same as in corresponding day 12 EBs
(Eomes) or higher (Fgf5 and Brachury). To validate these data we
subjected our Dnmt12/2 ESC lines stably complemented with
GFP-Dnmt1wt and GFP-Dnmt1C1229W to the same procedure
(Fig. S11). Complementation with the catalytically inactive GFP-
Dnmt1C1229W resulted in transcript levels of Oct4, Nanog and Tet1
very similar to those in parental Dnmt12/2 cells/EBs at every
stage. In contrast and as expected, stable complementation of
Dnmt12/2 cells/EBs with GFP-Dnmt1wt led to drastic silencing of
Oct4, Nanog and Tet1 in EBs, that, as in wt cells/EBs, was
maintained after EB dissociation and replating, regardless of the
presence or absence of LIF. Transcript levels of Fgf5, Brachury and
Eomes in Dnmt12/2 cells/EBs stably complemented with GFP-
Dnmt1wt and GFP-Dnmt1C1229W also showed similar dynamics to
Dnmt12/2 and wt cells/EBs, respectively, with some deviation
likely due to constitutive (unregulated) expression of GFP-Dnmt1
constructs.
These results clearly show that cells isolated from 12 days old
Dnmt12/2 and TKO EBs respond to the combined action of
dissociation and LIF stimulation by reverting to the undifferen-
tiated ESC state. This result is particularly striking in the case of
Dnmt12/2 EBs where differentiation programs are relatively
advanced as shown by high concordance of expression profiles
with those from wt EBs. In addition, the DNA methyltransferase
activity, rather than a non-catalytic function of Dnmt1, is required
to suppress the ability of cells from Dnmt12/2 EBs to revert to the
ESCs state upon dissociation and exposure to LIF. Together these
data underscore a fundamental role of DNA methylation in
restricting developmental plasticity by locking transcriptional states
during differentiation.
Discussion
The role of DNA methylation in controlling transcription
programs during mammalian development and lineage specifica-
tion has been mainly inferred from genomic methylcytosine
profiles in a limited selection of cell types and developmental
stages, while little information is available about how DNA
methylation and Dnmts actually affect transcription during
differentiation. In particular, expression data from differentiated
progeny of globally hypomethylated ESCs lacking specific Dnmts
are very scarce. This is likely in relation to reports of limited
survival or proliferation of Dnmt1 null and TKO cells upon
differentiation [28,44,45,47]. Consistent with this previous work,
we found that the average size of Dnmt1 null and especially TKO
EBs is reduced as compared to that of wt EBs. However, we could
maintain cultures of these mutant EBs for at least 24 days. EB
formation is an undirected differentiation model supporting the
specification of a broad range of cell fates and thus commonly used
to asses developmental potential. Using this system we found that
Dnmt1 null and TKO EBs exhibit residual transcription of
pluripotency master regulators Oct4 and Nanog even after 16 days
of culture. However, FACS analysis showed that by day 8 Oct4
protein is uniformly downregulated in all the cells of these mutant
EBs to the same basal levels as in wt EBs, suggesting homogeneous
exit from the ESC state. This is supported by the relatively high
concordance of genome-wide transcription changes in mutant
relative to wt EBs after 4 days of differentiation, including
downregulation of additional genes associated with pluripotent
stem cell states and upregulation of factors related to differentiated
lineages. However, by day 16 gene expression profiles in TKO
EBs reveal a high degree of divergence from those in wt EBs, while
expression changes in Dnmt1 null EBs are still concordant with
one third of all changes in wt EBs. On the one hand this represents
a previously unappreciated progression of transcription programs
in differentiated Dnmt1 null cells, on the other hand it reflects
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substantially impaired developmental potential in TKO as well as
Dnmt1 null cells. In this regard it is worth considering that while
the genome of TKO cells is virtually devoid of methylation, the
20% residual genomic methylcytosine in Dnmt12/2 ESCs is
mainly restricted to repetitive sequences [28,36,42]. Yet our
analysis reveals a remarkable difference between gene expression
profiles of Dnmt12/2 and TKO cells in response to differentiation
conditions. These differences must ultimately depend on the action
of Dnmt3a and 3b, either through sustained de novo methylation of
repetitive sequences, indirect effects or mechanisms independent
from their catalytic activity. Interestingly, ESCs lacking both
Ring1b and Eed, and thus functional Polycomb repressive
complexes (PRC) 1 and 2, have also been recently shown to
retain the ability to self renew, yet they fail to properly execute
differentiation programs and silence repetitive sequences, includ-
ing endogenous retroviral elements (ERVs) [23]. In particular,
ESCs lacking both PRC1 and 2 show twice the number of
derepressed genes as ESCs lacking either complex, where little
Figure 5. CpG island methylation and disregulated expression of selected bivalent genes in wt and mutant EBs. Transcript levels and
CpG island methylation of bivalent genes Nestin (A,B) and Sox1 (C,D) as well as the non-bivalent gene Tet1 (E,F) in undifferentiated ESCs (day 0) and at
day 4 and 16 of EB culture. (A,C,E) Transcript levels were measured by RT-qPCR in wt, Dnmt12/2 and TKO ESCs/EBs as indicated. Mean values and
standard errors from three independent biological replicates are shown. All values are normalized to undifferentiated wt ESCs. Asterisks indicates the
significance level p,0.05 (Student t-test). (B,D,F) DNA methylation analysis by bisulfite sequencing in wt ESCs/EBs. In the gene cartoons large arrows
indicate transcriptional start sites (TSS), open rectangles represent exons, grey shaded rectangles represent CpG islands and numbers indicate the
positions of their borders with respect to the TSS. Small arrows indicate the analyzed regions. In the panels grey and black squares indicate
unmethylated and methylated CpG sites, respectively. Percentages of total CpG methylation within the analyzed regions/clones are reported at the
bottom of each panel.
doi:10.1371/journal.pone.0052629.g005
DNA Methylation Restricts Developmental Fate
PLOS ONE | www.plosone.org 8 December 2012 | Volume 7 | Issue 12 | e52629
derepression of ERVs is observed, leading to the proposal that
repetitive sequences serve as a platform for gene silencing by PRC
complexes. This is reminiscent of the higher number of
disregulated genes in TKO versus Dnmt1 null EBs (roughly two
fold at day 4) and of substantial residual methylation of repetitive
sequences in Dnmt1 null cells. It is therefore tempting to speculate
that methylation of repetitive sequences may also serve as a
platform for gene silencing upon differentiation. Thus, there seem
to be striking parallels between the roles and possible modes of
action of the DNA methylation and Polycomb systems in
contributing to cell identity and developmental potential.
Upon initial lineage commitment some bivalent domains may
remain such to perpetuate the poised state for later differentiation
events, while most are thought to resolve by loss of H3K27me3 for
transcriptional activation or loss of H3K4me3 or both H3 marks
accompanied by gain of DNA methylation for definitive repression
as it has been proposed in the case of neural commitment [59,62].
If DNA methylation represented a general mechanism for
permanent silencing of bivalent genes in non-expressing lineages
most of these genes would be expected to be disregulated in
Dnmt1 null or at least TKO EBs, which we find not to be the case.
However, we show that the bivalent genes Nestin and Sox1, which
are both expressed in early neuroepithelial progenitors, do gain
methylation at their CpG islands in a subset of wt differentiated
cells and are disregulated in the absence of Dnmts. This suggests
that CpG island methylation contributes to silencing of Nestin and
Sox1 in specific lineages. By contrast, we did not detect CpG island
methylation for the bivalent genes Fgf5 and Brachyury (expressed in
primitive ectoderm and early mesoderm, respectively), which were
also disregulated in mutant EBs. These data are consistent with an
involvement of Dnmts in mediating stable silencing of selected
bivalent genes during differentiation through either direct or
indirect mechanisms. Further work is required to establish whether
CpG island methylation is the preferred silencing mechanism for
genes with function in the neuroectodermal lineage.
Regardless of bivalent nature, we also note that genes with roles
in neural fate specification are frequently upregulated in TKO
EBs. This is consistent with a recent report showing involvement of
DNMT3B in controlling neural selector genes upon neural
differentiation of human ESCs [63]. In this case knockdown of
Figure 6. LIF signaling induces reversion of cells from Dnmt12/2 and TKO EBs to the ESC state. (A) Overview of experimental set up. Day
12 EBs were dissociated and their cells were plated and further cultured for three days (R1–3) in the presence or absence of LIF. (B) Transcript levels of
pluripotency associated genes Oct4, Nanog and Tet1, as well as differentiation marker genes Fgf5, Brachyury and Eomes were determined by RT-qPCR
in undifferentiated ESCs (day 0), day 12 EBs and 1, 2 and 3 days after replating (R1–3). Wild type, Dnmt12/2 and TKO samples are represented in
shades of red, blue and green, respectively, as indicated in the box at the upper right corner. Mean values relative to wt ESCs (day 0) and standard
errors are from three independent biological replicates. Asterisks indicate significance levels: * p,0.05; ** p,0.001; *** p,0.0001 (Student t-test).
doi:10.1371/journal.pone.0052629.g006
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DNMT3B determined loss of H3K27me3 and EZH2 occupancy
(the H3K27 methyltransferase component of PRC2) at promoters
of affected genes, but not DNA methylation, suggesting once more
a role of a Dnmt in recruiting other silencing factors (in this case
DNMT3B recruiting PRC2).
We show that Dnmt1 null and TKO cells isolated from 12 days
old EBs can fully and rapidly revert to the undifferentiated ESC
state when plated in pluripotency promoting conditions. It is
highly unlikely that this is due to a subpopulation of undifferen-
tiated cells within day 12 Dnmt1 null and TKO EBs as our FACS
analysis of Oct4 protein profiles shows no distinct subpopulation of
living cells dissociated from these mutant EBs that express levels
above background (as defined by antibody isotype control; Fig. 2).
Importantly, the same background profiles are found in cells from
wt EBs, which do not respond to replating in the presence of LIF.
In addition, our genome wide expression analysis shows that Dnmt
deficient EBs, especially Dnmt12/2 EBs, upregulate differentiation
programmes to a substantial extent. However, in day 12 Dnmt
mutant EBs transcription of Oct4 and Nanog is not completely
silenced and upon dissociation and exposure to LIF both genes are
rapidly and fully reactivated. Interestingly, increased transcrip-
tional activity of Oct4, Nanog and Tet1 is also seen upon replating of
cells from Dnmt mutant EBs in the absence of LIF. Surprisingly,
during the following two days the levels of Oct4, Nanog and Tet1
transcripts in replated TKO cells gradually return to those present
in corresponding day 12 EBs, while they are maintained in
replated Dnmt12/2 cells. The reason for this difference between
Dnmt1 null and TKO cells is unclear. In this regard we note that
genes concordantly upregulated in wt and Dnmt12/2 EBs between
4 and 16 days of differentiation show highest enrichment for GO
terms associated with cell adhesion (p,1e26; Fig. S6A). Together
these results suggest that cell-to-cell contact within EBs contributes
to silencing of Oct4, Nanog and Tet1 and that this repressive effect is
released upon dissociation of hypomethylated EBs. However, the
transcriptional response of Oct4, Nanog and Tet1 to the release of
cell-to-cell contact is subordinate to silencing by promoter
methylation, as cells from wt EBs do not reactivate these genes
upon replating, regardless of LIF stimulation. Thus, although
additional epigenetic pathways are known to corepress Oct4 and
Nanog and may respond to cell adhesion conditions, our data show
that DNA methylation is crucial for complete and permanent
extinction of Oct4 and Nanog transcription and thus enforces
canalization of developmental fate upon differentiation.
Global inhibition of Dnmt activity was shown to facilitate
reprogramming of differentiated somatic cells to pluripotency
[64,65]. However, this approach may have undesired effects,
especially in the case of mechanism based inhibitors that lead to
the formation of covalent and potentially mutagenic Dnmt-DNA
adducts. Our observation that differentiated cells lacking only
Dnmt1 efficiently revert to the ESC state suggests that transient
and specific inhibition of Dnmt1 activity may be sufficient to
promote conversion of differentiated cell types to the pluripotent
state. However, this could also be counteracted by death of not yet
dedifferentiated cells as Dnmt1 ablation in differentiated cells was
shown to trigger apotosis at least in part mediated by p53 [66]. At
the same time functional p53 inactivation has been shown to
increase the efficiency of iPSC derivation by overcoming
proliferative senescence of differentiated cells [67–71]. Thus,
combining transient functional inactivation of Dnmt1 and p53
may have a synergistic effect on the reprogramming efficiency.
Indeed, p53 inactivation may favor rapid passive demethylation by
increasing proliferation rates and at the same time it may prevent
death of not yet dedifferentiated cells.
In conclusion, our results underscore a critical role of DNA
methylation and Dnmts in restricting developmental potential by
permanently sealing transcriptionally silent states, as in the case of
the pluripotency genes Oct4 and Nanog and genes involved in the
neuroectodermal lineage. In addition, our results lend support to
transient Dnmt1 inhibition as an approach for improved
reprogramming of differentiated cells to the pluripotent state,
which in turn suggests functional p53 inactivation as a potentially
synergistic strategy.
Materials and Methods
Cell and EB culture
The mouse wt, dnmt12/2 and TKO J1 ESC lines and respective
EBs were cultured as described previously [61]. For stable
complementation, dnmt12/2 ESCs were transfected with pCAG-
IRES-blast vectors with inserts encoding GFP-Dnmt1wt or GFP-
Dnmt1C1229W fusions [72]. Stable clones were selected either by
culture in the presence of blasticidin or by repeated FACS sorting.
Clones used in the present work were further selected as to express
steady state levels of GFP-Dnmt1 fusions similar to those of native
Dnmt1 in wt ESCs (Fig. S1A). For replating of cells from EBs, EBs
were washed three times with PBS and dissociated to single cells by
repeated cycles of Accutase treatment (PAA Laboratories GmbH)
at 37uC. Dissociated cells were diluted in EB medium (ES cell
medium without LIF), centrifuged and resuspended in fresh EB
medium. Equal numbers of cells were then seeded in duplicate on
gelatin-coated plates and LIF (ESGRO, Millipore) was added to
one of the duplicate plates to a final concentration of 1000 U/ml.
DNA and RNA isolation
Genomic DNA (gDNA) and total RNA from ESCs and EBs
were extracted using either the NucleoSpin Triprep Kit
(Macherey-Nagel) or the QIAmp DNA Mini Kit (QIAGEN) and
TRIzol reagent (Invitrogen), respectively. To minimize gDNA
contamination, RNA isolated with the Trizol reagent was digested
with recombinant RNase-free DNase I (Roche) and further
purified with the RNeasy kit (QIAGEN). The RNA isolation
procedure with NucleoSpin Triprep Kit already includes DNase I
treatment.
Expression analysis by reverse transcription-real time PCR
(RT-qPCR)
cDNA synthesis and qPCR were performed using either
TaqMan Gene expression assays (Applied Biosystems) or SYBR
Green detection as described previously [61,73]. Primer sequences
and TaqMan Gene Expression Assay ID numbers are listed in
Tables S1 and S2.
DNA methylation analysis
Bisulfite conversion of gDNA (0.5–1.5 mg) and PCR reactions
were performed as described previously [73]. All PCR amplifica-
tions involved semi-nested reactions. Primers (Tables S3 and S4)
were designed using MethPrimer [74]. CpG islands were identified
with the CpG Island Searcher using default settings [75].
Pyrosequencing reactions were performed by Varionostic GmbH
(Ulm, Germany). For bisulfite sequencing, PCR products were
subcloned using the StrataCloneTM PCR Cloning Kit and
StrataConeTM SoloPackH Competent Cells (Agilent Technologies)
according to the manufacturer’s instructions. Sequences were
analyzed with BISMA software using default settings [76].
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Fluorescence activated cell sorting (FACS) analysis
EBs were washed twice in PBS and incubated in Cell
Dissociation Buffer (Invitrogen) for 45 min at 37uC. An equal
volume of EB medium was added and EBs were dissociated to
single cells by vortexing. To distinguish dead from living cells, 7-
amino-actinomycin D (Invitrogen) was added at a concentration of
5 mg/ml for 20 min at 4uC. After multiple washing steps in PBS,
cells were fixed in Cytofix (BD biosciences) for 20 min at 4uC and
washed twice in Perm/Wash solution (BD bioscience). Antibody
staining was performed in Perm/Wash buffer for 30 min at 4uC
using Alexa FlourH 647 Mouse anti-Oct3/4 and Alexa FlourH 647
Mouse IgG1 K isotype control (BD Biosciences). After washing
twice with Perm/Wash buffer, cells were resuspended in Annexin
buffer (10 mM HEPES, 140 mM NaCl, 2.5 mM CaCl2, pH 7.4)
and analyzed with a FACS Aria II instrument (Becton Dickinson).
Data analysis was performed using FlowJo version 7.2.5.
Microarray and statistical analysis
Sample preparation for microarray analysis was performed
using the WT Expression Kit (Ambion) and WT Terminal
Labeling and Controls Kit (Affymetrix) with 300 ng input RNA.
Samples were hybridized to GeneChip Mouse Gene 1.0 ST
microarrays (Affymetrix) according to the manufacturer’s instruc-
tions. Quality control, normalization and further statistical
analyses were carried out using the R/Bioconductor programming
environment. Linear Models for Microarray Data (limma) was
used to compute fold changes and p-values [77]. Genes with a fold
change of 2 and a false discovery rate below 0.05 were considered
differentially expressed. Genes identified as differentially expressed
(Fig. 3B–D) and their expression fold change are listed in Table S5
(d0), S6 (d0–4) and S7 (d4–16). Gene ontology (GO), tissue
expression and chromosomal location analysis was performed
using DAVID [78,79]. For GO enrichment analysis the lowest
level of GO categories for biological process (GO_BP_ALL) were
used. A one-sided Kolmogorov-Smirnov test was used to compare
gene expression changes in wt and knockout EBs globally as well
as for bivalent and non-bivalent genes between day 0 and 4 of
differentiation (Fig. 4 and Fig. S8).
Accession codes
Microarray data have been deposited into the Gene Expression
Omnibus (GEO) database under the accession number
GSE36679.
Supporting Information
Figure S1 Stable complementation of Dnmt12/2 ESCs
with GFP-Dnmt1wt, but not the catalytically inactive
mutant GFP-Dnmt1C1229W rescues silencing and pro-
moter methylation of Oct4 and Nanog upon differenti-
ation as EBs.
(TIF)
Figure S2 Analysis of genes differentially expressed in
TKO ESCs compared to wt ESCs (related to Fig. 3B).
(TIF)
Figure S3 Gene ontology enrichment and cell type
specific expression of concordantly regulated genes in
wt, Dnmt12/2 and TKO EBs after 4 days of differenti-
ation (related to Fig. 3C).
(TIF)
Figure S4 Gene ontology enrichment and cell type
specific expression of concomitantly upregulated genes
in wt, Dnmt12/2 and TKO EBs during day 4–16 of
differentiation (related to Fig. 3D).
(TIF)
Figure S5 Enriched GO categories of commonly upre-
gulated genes in wt and Dnmt12/2 EBs after 4 days of
differentiation (related to Fig. 3C).
(TIF)
Figure S6 Gene ontology enrichment and tissue specific
expression of concordantly regulated genes in wt and
Dnmt12/2 EBs during day 4–16 of differentiation
(related to Fig. 3D).
(TIF)
Figure S7 Dnmt3a and 3b transcript leves during EB
differentiation of wt and Dnmt12/2 ESCs.
(TIF)
Figure S8 Expression changes of non-bivalent and
bivalent genes in TKO and Dnmt12/2 EBs relative to
wt EBs between day 0 and 4 of differentiation (related to
Fig. 4).
(TIF)
Figure S9 GO and tissue expression enrichment for
genes commonly upregulated in Dnmt12/2 and TKO
EBs as well as exclusively upregulated in Dnmt12/2 or
TKO EBs after 4 days of differentiation (related to
Fig. 3C).
(TIF)
Figure S10 Transcript levels and CpG island methyla-
tion of bivalent genes Brachury and Fgf5 (related to
Fig. 5).
(TIF)
Figure S11 Stable complementation with GFP-Dnmt1wt,
but not the catalytically inactive mutant GFP-
Dnmt1C1229W, abolishes reversion of cells from
Dnmt12/2 EBs to the ESC state upon dissociation and
LIF stimulation (related to Fig. 6).
(TIF)
Table S1 TaqMan Assay ID numbers for qPCR.
(PDF)
Table S2 Primer Sequences for qPCR.
(PDF)
Table S3 Primer Sequences for bisulfite Sequencing.
(PDF)
Table S4 Primer Sequences for Pyrosequencing.
(PDF)
Table S5 Differentially expressed genes in Dnmt12/2
and TKO ESCs (related to Fig. 3B).
(XLSX)
Table S6 Differentially expressed genes between d0–4
of differentiation (related to Fig. 3C).
(XLSX)
Table S7 Differentially expressed genes between d4–16
of differentiation (related to Fig. 3D).
(XLSX)
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